i-Seq Biotechnology Overview

  • Year Founded
  • 2024

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Early Stage VC

  • Investors
  • 1

i-Seq Biotechnology General Information

Description

Developer of medical technology designed to create broad-spectrum vaccines and therapeutics for infectious diseases. The company uses CRISPR interference screening to assess genome-wide gene fitness in a single step and identify new vaccine antigens and therapeutic targets, enabling healthcare providers and researchers to develop safer and more effective treatments for human infections.

Contact Information

Website
www.i-seq.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 775 North University Boulevard
  • Suite 150
  • Mobile, AL 36608
  • United States
Primary Industry
Drug Discovery
Vertical(s)
Corporate Office
  • 775 North University Boulevard
  • Suite 150
  • Mobile, AL 36608
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

i-Seq Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-2024 Completed Generating Revenue
To view i-Seq Biotechnology’s complete valuation and funding history, request access »

i-Seq Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

i-Seq Biotechnology Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
VIC Technology Venture Development Venture Capital Minority
To view i-Seq Biotechnology’s complete investors history, request access »

i-Seq Biotechnology FAQs

  • When was i-Seq Biotechnology founded?

    i-Seq Biotechnology was founded in 2024.

  • Where is i-Seq Biotechnology headquartered?

    i-Seq Biotechnology is headquartered in Mobile, AL.

  • What is the size of i-Seq Biotechnology?

    i-Seq Biotechnology has 3 total employees.

  • What industry is i-Seq Biotechnology in?

    i-Seq Biotechnology’s primary industry is Drug Discovery.

  • Is i-Seq Biotechnology a private or public company?

    i-Seq Biotechnology is a Private company.

  • What is i-Seq Biotechnology’s current revenue?

    The current revenue for i-Seq Biotechnology is .

  • Who are i-Seq Biotechnology’s investors?

    VIC Technology Venture Development has invested in i-Seq Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process